EP1240178A4 - VERFAHREN UND MATERIALIEN MIT BEZUG ZU PROTHROMBINASE-äHNLICHEN POLYPEPTIDEN UND POLYNUKLEOTIDEN. - Google Patents

VERFAHREN UND MATERIALIEN MIT BEZUG ZU PROTHROMBINASE-äHNLICHEN POLYPEPTIDEN UND POLYNUKLEOTIDEN.

Info

Publication number: EP1240178A4
Authority: EP; European Patent Office
Prior art keywords: prothrombinase; polynucleotides; polypeptides; methods; substances relating
Prior art date: 1999-12-23
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Withdrawn

Application number

EP00989432A

Other languages

English (en)

French (fr)

Other versions

EP1240178A2 (de

Inventor

Dana A Haley

Bryan J Boyle

Ho Alice Suk-Yue

Ping Zhou

Nancy K Mize

Chiauyun Kuo

Matthew C Arterburn

Y Tom Tang

Chenghua Liu

Radoje Drmanac

Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

Nuvelo Inc

Original Assignee

Nuvelo Inc

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1999-12-23

Filing date

2000-12-22

Publication date

2004-06-30

2000-06-17 Priority claimed from US09/596,196 external-priority patent/US6586390B1/en

2000-12-22 Application filed by Nuvelo Inc filed Critical Nuvelo Inc

2002-09-18 Publication of EP1240178A2 publication Critical patent/EP1240178A2/de

2004-06-30 Publication of EP1240178A4 publication Critical patent/EP1240178A4/de

Status Withdrawn legal-status Critical Current

Classifications

- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/14—Hydrolases (3)
- C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
- C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
- C12N9/64—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
- C12N9/6421—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
- C12N9/6424—Serine endopeptidases (3.4.21)
- C12N9/6432—Coagulation factor Xa (3.4.21.6)
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/02—Nutrients, e.g. vitamins, minerals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
- C07K14/70503—Immunoglobulin superfamily
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/14—Hydrolases (3)
- C12N9/16—Hydrolases (3) acting on ester bonds (3.1)
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Y—ENZYMES
- C12Y304/00—Hydrolases acting on peptide bonds, i.e. peptidases (3.4)
- C12Y304/21—Serine endopeptidases (3.4.21)
- C12Y304/21006—Coagulation factor Xa (3.4.21.6)
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Organic Chemistry (AREA)
Engineering & Computer Science (AREA)
General Health & Medical Sciences (AREA)
Bioinformatics & Cheminformatics (AREA)
Medicinal Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Pharmacology & Pharmacy (AREA)
General Chemical & Material Sciences (AREA)
Animal Behavior & Ethology (AREA)
Chemical Kinetics & Catalysis (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Biomedical Technology (AREA)
Zoology (AREA)
Genetics & Genomics (AREA)
Neurology (AREA)
Wood Science & Technology (AREA)
Neurosurgery (AREA)
Immunology (AREA)
Diabetes (AREA)
Biochemistry (AREA)
General Engineering & Computer Science (AREA)
Molecular Biology (AREA)
Biotechnology (AREA)
Oncology (AREA)
Obesity (AREA)
Communicable Diseases (AREA)
Rheumatology (AREA)
Microbiology (AREA)
Orthopedic Medicine & Surgery (AREA)
Physical Education & Sports Medicine (AREA)
Hematology (AREA)
Psychology (AREA)
Toxicology (AREA)
Emergency Medicine (AREA)
Nutrition Science (AREA)
Pain & Pain Management (AREA)

EP00989432A 1999-12-23 2000-12-22 VERFAHREN UND MATERIALIEN MIT BEZUG ZU PROTHROMBINASE-äHNLICHEN POLYPEPTIDEN UND POLYNUKLEOTIDEN. Withdrawn EP1240178A4 (de)

Applications Claiming Priority (13)

Application Number	Priority Date	Filing Date	Title
US47127599A	1999-12-23	1999-12-23
US471275		1999-12-23
US48872500A	2000-01-21	2000-01-21
US488725		2000-01-21
US49140400A	2000-01-25	2000-01-25
US491404		2000-01-25
US55231700A	2000-04-25	2000-04-25
US552317		2000-04-25
US09/596,196 US6586390B1 (en)	2000-01-21	2000-06-17	Methods and materials relating to novel prothrombinase-like polypeptides and polynucleotides
US596196		2000-06-17
US64331300A	2000-08-31	2000-08-31
US643313		2000-08-31
PCT/US2000/035061 WO2001053456A2 (en)	1999-12-23	2000-12-22	Methods and materials relating to prothrombinase-like polypeptides and polynucleotides

Publications (2)

Publication Number	Publication Date
EP1240178A2 EP1240178A2 (de)	2002-09-18
EP1240178A4 true EP1240178A4 (de)	2004-06-30

Family

ID=27560029

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
EP00989432A Withdrawn EP1240178A4 (de)	1999-12-23	2000-12-22	VERFAHREN UND MATERIALIEN MIT BEZUG ZU PROTHROMBINASE-äHNLICHEN POLYPEPTIDEN UND POLYNUKLEOTIDEN.

Country Status (4)

Country	Link
EP (1)	EP1240178A4 (de)
AU (1)	AU783762B2 (de)
CA (1)	CA2395749A1 (de)
WO (1)	WO2001053456A2 (de)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
WO2002042448A1 (fr) *	2000-11-22	2002-05-30	Yamanouchi Pharmaceutical Co., Ltd.	Nouveau polypeptide
CA2399569A1 (en)	2001-09-25	2003-03-25	Yusuke Nakamura	Diagnostic markers and drug targets for treatment of cancer
AU2002329061A1 (en)	2001-09-25	2003-04-07	Japan As Represented By The President Of The University Of Tokyo	Gene and protein relating to hepatocellular carcinoma
WO2004024077A2 (en) *	2002-09-11	2004-03-25	Genentech, Inc.	Novel composition and methods for the treatment of psoriasis

Citations (1)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
WO2001005825A2 (en) *	1999-07-16	2001-01-25	Hyseq, Inc.	Nucleic acid sequences encoding putative angiopoietin proteins

2000
- 2000-12-22 EP EP00989432A patent/EP1240178A4/de not_active Withdrawn
- 2000-12-22 CA CA002395749A patent/CA2395749A1/en not_active Abandoned
- 2000-12-22 WO PCT/US2000/035061 patent/WO2001053456A2/en not_active Ceased
- 2000-12-22 AU AU25936/01A patent/AU783762B2/en not_active Ceased

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
WO2001005825A2 (en) *	1999-07-16	2001-01-25	Hyseq, Inc.	Nucleic acid sequences encoding putative angiopoietin proteins

Non-Patent Citations (6)

* Cited by examiner, † Cited by third party
Title
DATABASE EMBL [online] EBI; 17 November 1999 (1999-11-17), BIRREN B. ET AL.: "Homo sapiens clone RP-11-21G19, WORKING DRAFT SEQUENCE, 11 unordered pieces.", XP002275729, Database accession no. AC015500 *
DATABASE EMBL [online] EBI; 3 September 1994 (1994-09-03), RUEGG C.: "H. sapiens mRNA for fibrinogen-like protein (pT49 protein).", XP002275808, Database accession no. Z36531 *
KIM I ET AL: "Molecular cloning and characterization of a novel angiopoietin family protein, angiopoietin-3.", FEBS LETTERS. NETHERLANDS 29 JAN 1999, vol. 443, no. 3, 29 January 1999 (1999-01-29), pages 353 - 356, XP004259174, ISSN: 0014-5793 *
MARAZZI S ET AL: "Characterization of human fibroleukin, a fibrinogen-like protein secreted by T lymphocytes.", JOURNAL OF IMMUNOLOGY (BALTIMORE, MD.: 1950) UNITED STATES 1 JUL 1998, vol. 161, no. 1, Z36531, 1 July 1998 (1998-07-01), pages 138 - 147, XP002254978, ISSN: 0022-1767 *
See also references of WO0153456A3 *
YUWARAJ S ET AL: "Genomic characterization, localization, and functional expression of FGL2, the human gene encoding fibroleukin: a novel human procoagulant.", GENOMICS. UNITED STATES 1 FEB 2001, vol. 71, no. 3, 1 February 2001 (2001-02-01), pages 330 - 338, XP004432297, ISSN: 0888-7543 *

Also Published As

Publication number	Publication date
WO2001053456A3 (en)	2002-05-30
WO2001053456A9 (en)	2002-12-05
WO2001053456A8 (en)	2002-07-04
AU2593601A (en)	2001-07-31
EP1240178A2 (de)	2002-09-18
AU783762B2 (en)	2005-12-01
CA2395749A1 (en)	2001-07-26
WO2001053456A2 (en)	2001-07-26

Publication	Publication Date	Title
IS5541A (is)	2000-06-19	Áfangatöflur til inntöku
NO993497L (no)	1999-09-30	Kjeveenhet til bruk i en krafttang
GB2325404B (en)	2001-07-11	Improvements in or relating to a support device
ITBO930493A0 (it)	1993-12-10	Macchina comprimitrice rotativa
GB9715540D0 (en)	1997-10-01	Improvements in or relating to dross presses
DE59809603D1 (de)	2003-10-23	Rundlaufpresse
EP1240178A4 (de)	2004-06-30	VERFAHREN UND MATERIALIEN MIT BEZUG ZU PROTHROMBINASE-äHNLICHEN POLYPEPTIDEN UND POLYNUKLEOTIDEN.
GB2325945B (en)	1999-02-17	Improvements in or relating to a pannelling arrangement
EP1242580A4 (de)	2003-05-14	Verfahren und materialien im zusammenhang mit semaphorin-artigen polypeptiden und polynukleotiden
GB9825280D0 (en)	1999-01-13	Improvements in or relating to a sensor arrangement
AU3486501A (en)	2001-08-14	Methods and materials relating to alpha-2-macroglobulin-like polypeptides and polynucleotides
GB9827004D0 (en)	1999-02-03	Improvements in or relating to a scaffolding arrangement
GB2321646B (en)	2001-10-17	Improvements in or relating to electrodes
DE59811575D1 (de)	2004-07-22	Filtereinrichtung in Modulbauweise
GB2344541B (en)	2002-11-06	Improvements in or relating to a device for passing a line
GB9713957D0 (en)	1997-09-03	Improvements in or relating to a switch
DE59804973D1 (de)	2002-09-05	Rundlauf-Tablettenpresse
DE69821955D1 (de)	2004-04-01	Neue dreidimensionale elektrode
DE69803558D1 (de)	2002-03-14	Bügelpresse
GB2322145B (en)	2000-10-25	Improvements in or relating to a structural arrangement
BR7702010U (pt)	1999-08-03	Disposição introduzida em máquina de assar
GB2328456B (en)	2001-07-25	Improvements in or relating to spacers
PT102274B (pt)	2003-03-31	Disposicao introduzida numa uniao rotativa
DE69820599T2 (de)	2004-10-07	Gitterelektroden fur eine Anzeigevorrichtung
GB9719684D0 (en)	1997-11-19	Improvements in or relating to a support device

Legal Events

Date	Code	Title	Description
2002-08-02	PUAI	Public reference made under article 153(3) epc to a published international application that has entered the european phase	Free format text: ORIGINAL CODE: 0009012
2002-09-18	17P	Request for examination filed	Effective date: 20020624
2002-09-18	AK	Designated contracting states	Kind code of ref document: A2 Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE TR
2002-09-18	AX	Request for extension of the european patent	Free format text: AL;LT;LV;MK;RO;SI
2002-12-04	RIN1	Information on inventor provided before grant (corrected)	Inventor name: ZHOU, PING Inventor name: KUO, CHIAUYUN Inventor name: SUK-YUE HO, ALICE Inventor name: TANG, Y., TOM Inventor name: BOYLE, BRYAN, J. Inventor name: ARTERBURN, MATTHEW, C. Inventor name: HALEY, DANA, A. Inventor name: MIZE, NANCY, K.
2003-07-02	RAP1	Party data changed (applicant data changed or rights of an application transferred)	Owner name: NUVELO INC.
2003-09-10	RAP1	Party data changed (applicant data changed or rights of an application transferred)	Owner name: NUVELO, INC.
2003-11-05	RTI1	Title (correction)	Free format text: METHODS AND MATERIALS RELATING TO PROTHROMBINASE-LIKE POLYPEPTIDES AND POLYNUCLEOTIDES.
2004-06-16	RIC1	Information provided on ipc code assigned before grant	Ipc: 7C 07K 14/475 B Ipc: 7C 07K 14/705 A
2004-06-30	A4	Supplementary search report drawn up and despatched	Effective date: 20040513
2005-03-16	17Q	First examination report despatched	Effective date: 20050201
2006-10-06	STAA	Information on the status of an ep patent application or granted ep patent	Free format text: STATUS: THE APPLICATION HAS BEEN WITHDRAWN
2006-11-08	18W	Application withdrawn	Effective date: 20061002